Eli Lilly and Company

États‑Unis d’Amérique

1-100 de 240 pour Eli Lilly and Company

Trier par

Recheche Texte

Marque
Canada - CIPO
Excluant les filiales

Affiner par

Reset Report

Date

Classe NICE

180

Statut

171

Résultats pour

marques

1 2 3 Prochaine page

1.

MISCELLANEOUS DESIGN

Numéro d'application	232153500
Statut	En instance
Date de dépôt	2024-04-15
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Pharmaceutical preparations for the treatment of cancer (1) Medical information services in the field of cancer.

2. PALJURNI

Numéro d'application	231623500
Statut	En instance
Date de dépôt	2024-03-18
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

3.

MISCELLANEOUS DESIGN

Numéro d'application	230786000
Statut	En instance
Date de dépôt	2024-01-31
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Providing medical information; providing medical information in the field of Alzheimer's

4. LILLYTAP

Numéro d'application	230647400
Statut	En instance
Date de dépôt	2024-01-24
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	09 - Appareils et instruments scientifiques et électriques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Near field communication (NFC) tags for the purpose of tracking and authenticating pharmaceutical products and providing pharmaceutical product information. (1) Medical information services provided via the Internet.

5.

L

Numéro d'application	229398800
Statut	En instance
Date de dépôt	2023-11-21
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Pharmaceutical preparations for medicinal purposes in tablet form; pharmaceutical preparations (1) Medical information services; Arranging and providing medical information services relating to pharmaceuticals, namely providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

6. KWIKPEN

Numéro d'application	229259800
Statut	En instance
Date de dépôt	2023-11-13
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.

7.

V

Numéro d'application	229013900
Statut	En instance
Date de dépôt	2023-11-01
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Pharmaceutical preparations. (1) Medical information services in the field of inflammatory bowel disease and autoimmune diseases and disorders.

8. >HAIR

Numéro d'application	228752100
Statut	En instance
Date de dépôt	2023-10-18
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Medical information services in the field of autoimmune diseases.

9.

OMVOH

Numéro d'application	228754900
Statut	En instance
Date de dépôt	2023-10-18
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Pharmaceutical preparations (1) Medical Information services in the field of inflammatory bowel disease and autoimmune diseases and disorders

10. LILLYDIRECT

Numéro d'application	228417400
Statut	En instance
Date de dépôt	2023-09-28
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 09 - Appareils et instruments scientifiques et électriques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) House mark for a full line of pharmaceutical preparations. (2) Downloadable software for telehealth and telemedicine operations; downloadable computer software for prescribing, ordering, filling, managing, and providing information regarding prescription usage, dosage and directions; downloadable software for enabling patients to review details about medications and receive automated warnings of potential adverse interactions of medications; downloadable software for enabling patients to request, receive, track shipment of, and manage prescriptions and orders for pharmaceuticals; downloadable software for enabling patients to access general medical, health, and wellness information and advice. (1) Healthcare services; medical services; arranging and providing medical information services relating to pharmaceuticals, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals. (2) Telemedicine services

11. LILLYDIRECT

Numéro d'application	228419100
Statut	En instance
Date de dépôt	2023-09-28
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	35 - Publicité; Affaires commerciales 42 - Services scientifiques, technologiques et industriels, recherche et conception 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Mail order pharmacy services (2) Pharmacy services; online retail pharmacy services; online retail store services featuring pharmaceuticals; online retail pharmacy services for the ordering, purchase, and delivery of pharmaceuticals; pharmaceutical services, namely, processing prescription orders (3) Platform as a service featuring computer software to permit users to identify, request and receive pharmacy products

12. NATSIMLY

Numéro d'application	228423700
Statut	En instance
Date de dépôt	2023-09-28
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

13. MAGNOL.AI

Numéro d'application	228188400
Statut	En instance
Date de dépôt	2023-09-19
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	42 - Services scientifiques, technologiques et industriels, recherche et conception 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Providing medical and scientific research information in the field of pharmaceuticals and clinical trials (2) Providing data captured from wearable biosensors in the field of pharmaceuticals and clinical trials.

14. MONMOUNJARO

Numéro d'application	227885500
Statut	En instance
Date de dépôt	2023-09-01
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Medical information services in the field of diabetes and weight loss

15. mymounjaro

Numéro d'application	227808300
Statut	En instance
Date de dépôt	2023-08-30
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Medical information services in the field of diabetes and weight loss

16.

M

Numéro d'application	227225100
Statut	En instance
Date de dépôt	2023-07-27
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders and obesity. (1) Medical information services in the field of diabetes, endocrine diseases and disorders, metabolic diseases and disorders and obesity.

17.

MISCELLANEOUS DESIGN

Numéro d'application	227107000
Statut	En instance
Date de dépôt	2023-07-21
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

18.

MISCELLANEOUS DESIGN

Numéro d'application	227109500
Statut	En instance
Date de dépôt	2023-07-21
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Pharmaceutical preparations for the treatment of cancer (1) Medical information services in the field of oncology

19. MAGNOLAI

Numéro d'application	226558900
Statut	En instance
Date de dépôt	2023-06-22
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	42 - Services scientifiques, technologiques et industriels, recherche et conception 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

20. KRUVE

Numéro d'application	225215700
Statut	En instance
Date de dépôt	2023-04-14
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

21. ONSWIK

Numéro d'application	225220400
Statut	En instance
Date de dépôt	2023-04-14
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

22. YUZEVNI

Numéro d'application	223341900
Statut	En instance
Date de dépôt	2023-01-12
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.

23.

E

Numéro d'application	222752200
Statut	En instance
Date de dépôt	2022-12-12
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

24. EMTOAH

Numéro d'application	222752300
Statut	En instance
Date de dépôt	2022-12-12
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

25. KAYLUNRIE

Numéro d'application	221272000
Statut	En instance
Date de dépôt	2022-09-29
Propriétaire	ELI LILLY AND COMPANY (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; pharmaceutical preparations

26. INLURIYO

Numéro d'application	221255500
Statut	En instance
Date de dépôt	2022-09-28
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; pharmaceutical preparations

27. LELUNEVAY

Numéro d'application	221255400
Statut	En instance
Date de dépôt	2022-09-28
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; pharmaceutical preparations

28.

MISCELLANEOUS DESIGN

Numéro d'application	220573000
Statut	En instance
Date de dépôt	2022-08-24
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; pharmaceutical preparations.

29. EBGLASS

Numéro d'application	220393900
Statut	En instance
Date de dépôt	2022-08-12
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.

30. TEBGLYSS

Numéro d'application	220024700
Statut	En instance
Date de dépôt	2022-07-26
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

31. LEBGLYSS

Numéro d'application	220009500
Statut	En instance
Date de dépôt	2022-07-25
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.

32. EBGLISS

Numéro d'application	220009600
Statut	En instance
Date de dépôt	2022-07-25
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.

33. EBGLYRS

Numéro d'application	220009400
Statut	En instance
Date de dépôt	2022-07-25
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.

34.

M

Numéro d'application	219490600
Statut	En instance
Date de dépôt	2022-06-29
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of obesity;

35. ZEPBOUND

Numéro d'application	218902800
Statut	En instance
Date de dépôt	2022-06-01
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

36. JEYCIO

Numéro d'application	218768800
Statut	En instance
Date de dépôt	2022-05-25
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

37. TEMPOSMART

Numéro d'application	217221400
Statut	Enregistrée
Date de dépôt	2022-03-11
Date d'enregistrement	2024-02-19
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	09 - Appareils et instruments scientifiques et électriques

Produits et services

(1) Downloadable computer software to facilitate support and sharing of health information for patients living with diabetes and diabetes-related conditions; downloadable computer software, namely, software for diabetes management and glucose tracking; downloadable mobile application to facilitate monitoring of health and wellness data to patients living with diabetes and diabetes-related conditions; downloadable mobile application to facilitate support and sharing of health information for patients living with diabetes and diabetes-related conditions;

38. DAVNUO

Numéro d'application	216818000
Statut	En instance
Date de dépôt	2022-02-23
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

39. HYPORET

Numéro d'application	215219100
Statut	En instance
Date de dépôt	2021-12-07
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 10 - Appareils et instruments médicaux

Produits et services

(1) Injectable pharmaceuticals including antibiotics, barbiturates and vaccines. (2) A disposable syringe

40. JAYPIRCA

Numéro d'application	214868900
Statut	En instance
Date de dépôt	2021-11-19
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, osteoarthritis, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; vascular diseases; Diagnostic agents, preparations and substances for medical diagnostic purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases.

41. KISUNLA

Numéro d'application	214869000
Statut	En instance
Date de dépôt	2021-11-19
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

42. CIALIS FOR MEN

Numéro d'application	214567600
Statut	En instance
Date de dépôt	2021-11-08
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical and medicinal preparations for treatment of sexual dysfunction; pharmaceutical and medicinal preparations for prevention of sexual dysfunction

43. EBGLYSS

Numéro d'application	213503900
Statut	En instance
Date de dépôt	2021-09-22
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment, prevention and diagnosis of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, osteoarthritis, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; vascular diseases; Diagnostic agents, preparations and substances for medical diagnostic purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases.

44. TYVNI

Numéro d'application	211857800
Statut	Enregistrée
Date de dépôt	2021-07-02
Date d'enregistrement	2023-08-30
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely pharmaceutical preparations for the treatment of cancer.

45. TEMPO EASE

Numéro d'application	211354900
Statut	En instance
Date de dépôt	2021-06-10
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	10 - Appareils et instruments médicaux

Produits et services

(1) Infusion sets; infusion pumps; infusion set accessories, namely inserters.

46. ADGLYSS

Numéro d'application	209849200
Statut	En instance
Date de dépôt	2021-04-08
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

47. LEBVANAH

Numéro d'application	209849300
Statut	En instance
Date de dépôt	2021-04-08
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

48. ZOYFICENT

Numéro d'application	209771000
Statut	En instance
Date de dépôt	2021-04-07
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

49. JOYPERA

Numéro d'application	209770900
Statut	En instance
Date de dépôt	2021-04-07
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, osteoarthritis, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; vascular diseases; Diagnostic agents, preparations and substances for medical diagnostic purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases.

50. TYYVYYT

Numéro d'application	207865200
Statut	Enregistrée
Date de dépôt	2021-01-20
Date d'enregistrement	2023-03-01
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer

51. JAYYO

Numéro d'application	207802700
Statut	En instance
Date de dépôt	2021-01-16
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

52. OMBYNCA

Numéro d'application	207206100
Statut	En instance
Date de dépôt	2020-12-17
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Coronavirus disease.

53. DAVNUO

Numéro d'application	207206400
Statut	En instance
Date de dépôt	2020-12-17
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Coronavirus disease.

54. NETZUVY

Numéro d'application	207206500
Statut	En instance
Date de dépôt	2020-12-17
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Coronavirus disease.

55.

LYUMJEV

Numéro d'application	204708900
Statut	En instance
Date de dépôt	2020-08-20
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of Alzheimer's disease; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely atopic dermatitis, psoriasis, skin cancer and eczema; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of central nervous system (CNS) diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, diabetes, dyslipidemia; Pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus; Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis; Pharmaceutical preparations for the treatment of kidney diseases and disorders, liver diseases and disorders, lupus; Pharmaceutical preparations for the treatment of mental diseases and disorders, namely mood disorders, schizophrenia; Pharmaceutical preparations for the treatment of cognitive and bipolar disorders, epilepsy, and cerebral palsy; Pharmaceutical preparations for the treatment of metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis; Pharmaceutical preparations for the treatment of muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy; Pharmaceutical preparations for the treatment of neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia; Pharmaceutical preparations for the treatment of neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; Radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and pain.

56. PREIGHZ

Numéro d'application	203367300
Statut	En instance
Date de dépôt	2020-06-10
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; Diagnostic reagents for medical diagnostic use; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases and oncology and pain

57. ZEPJURNI

Numéro d'application	202890200
Statut	En instance
Date de dépôt	2020-05-19
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease and dementia, neurological disorders namely, mild cognitive impairment and multiple sclerosis, obesity, pain relief, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

58. MAYPELOG

Numéro d'application	202784900
Statut	Enregistrée
Date de dépôt	2020-05-13
Date d'enregistrement	2023-01-11
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Insulin

59. LIPRYLOG

Numéro d'application	202785300
Statut	Enregistrée
Date de dépôt	2020-05-13
Date d'enregistrement	2023-01-11
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Insulin

60. LIPRULOG

Numéro d'application	202785000
Statut	Enregistrée
Date de dépôt	2020-05-13
Date d'enregistrement	2023-01-11
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Insulin

61. LYPRULOG

Numéro d'application	202785100
Statut	Enregistrée
Date de dépôt	2020-05-13
Date d'enregistrement	2023-01-11
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Insulin

62. LIPRELOG

Numéro d'application	202785200
Statut	Enregistrée
Date de dépôt	2020-05-13
Date d'enregistrement	2023-01-11
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Insulin

63. OMVOH

Numéro d'application	202330400
Statut	En instance
Date de dépôt	2020-04-17
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis.

64. ZESQE

Numéro d'application	201932900
Statut	En instance
Date de dépôt	2020-03-25
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

65. BRYLZ

Numéro d'application	201933000
Statut	En instance
Date de dépôt	2020-03-25
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

66. HILLTHRU

Numéro d'application	201916700
Statut	En instance
Date de dépôt	2020-03-24
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

67. MOUNJARO

Numéro d'application	201916600
Statut	Enregistrée
Date de dépôt	2020-03-24
Date d'enregistrement	2023-03-22
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

68. LYUMJEV

Numéro d'application	201666600
Statut	En instance
Date de dépôt	2020-03-10
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

69. RETKEVMO

Numéro d'application	201346700
Statut	En instance
Date de dépôt	2020-02-21
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

70. TEMPO SMART PEN

Numéro d'application	200749000
Statut	Enregistrée
Date de dépôt	2020-01-22
Date d'enregistrement	2022-11-16
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 10 - Appareils et instruments médicaux

Produits et services

(1) Wireless insulin pen modules, namely, wireless insulin injectors sold filled with insulin. (2) Wireless dose detection modules attachable to insulin pens for transmission of information on insulin delivery, timing, glucose information and glucose levels.

71. RETEVMO

Numéro d'application	198386000
Statut	En instance
Date de dépôt	2019-09-05
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

72. TEMPO PEN

Numéro d'application	198082000
Statut	Enregistrée
Date de dépôt	2019-08-15
Date d'enregistrement	2022-11-02
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Wireless insulin pen modules, namely, wireless insulin injectors sold filled with insulin.

73. RETZELEQ

Numéro d'application	196407200
Statut	En instance
Date de dépôt	2019-05-21
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

74. RETKEO

Numéro d'application	196407100
Statut	En instance
Date de dépôt	2019-05-21
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

75. LIUMJEV

Numéro d'application	196343400
Statut	En instance
Date de dépôt	2019-05-16
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, and dementia, neurological disorders namely mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

76.

THE MIGRAINE TRUTH

Numéro d'application	195724000
Statut	En instance
Date de dépôt	2019-04-15
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	35 - Publicité; Affaires commerciales 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Promoting public interest and awareness in the field of pain. (2) Medical information services in the field of pain.

77. ZYMBOSI

Numéro d'application	195320800
Statut	En instance
Date de dépôt	2019-03-22
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain.

78. TEMPO SMART BUTTON

Numéro d'application	194829100
Statut	Enregistrée
Date de dépôt	2019-02-26
Date d'enregistrement	2022-12-11
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	09 - Appareils et instruments scientifiques et électriques 10 - Appareils et instruments médicaux

Produits et services

(1) Wireless dose detection modules attachable to insulin pens for the transmission of information on insulin delivery, timing, glucose information and glucose levels.

79.

HER BREAST CANCER IS DIFFERENT HIGH PROLIFERATION RESISTANT HIGH K167 CDK 4&6 HIGH TUMOR GRADE PR-NEGATIVE LUNG METASTACES LIVER METASTACES RAPID RECURRENCE

Numéro d'application	194195900
Statut	Enregistrée
Date de dépôt	2019-01-22
Date d'enregistrement	2023-01-10
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	35 - Publicité; Affaires commerciales

Produits et services

(1) Promoting public interest and awareness of metastatic breast cancer.

80. KEPEMRY

Numéro d'application	194183800
Statut	Enregistrée
Date de dépôt	2019-01-21
Date d'enregistrement	2022-12-09
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

81. KEPTEMRY

Numéro d'application	194183900
Statut	Enregistrée
Date de dépôt	2019-01-21
Date d'enregistrement	2022-12-09
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

82. TEMPO

Numéro d'application	193687300
Statut	En instance
Date de dépôt	2018-12-18
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 09 - Appareils et instruments scientifiques et électriques 10 - Appareils et instruments médicaux 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Insulin pen modules, namely, insulin injectors sold filled with insulin, utilizing wireless technology (2) Computer software application for management of diabetes-related data; downloadable cloud computing software for use in managing diabetes (3) Dose detection modules attachable to insulin pens for transmission of data utilizing wireless technology (1) Medical information services in the field of diabetes

83. MISUVA

Numéro d'application	193243900
Statut	Enregistrée
Date de dépôt	2018-11-26
Date d'enregistrement	2022-07-11
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain.

84. MISUVYA

Numéro d'application	193244000
Statut	Enregistrée
Date de dépôt	2018-11-26
Date d'enregistrement	2022-07-11
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain.

85.

TYVYT

Numéro d'application	193166900
Statut	Enregistrée
Date de dépôt	2018-11-21
Date d'enregistrement	2024-03-12
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 35 - Publicité; Affaires commerciales 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the immune system, pharmaceutical preparations for the treatment of autoimmune diseases, metabolic diseases, blood diseases, diabetes, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, reproductive system diseases and disorders, namely uterine fibroids, endometriosis, benign prostatic hyperplasia and polycystic ovarian syndrome, respiratory system diseases, central and peripheral nervous system diseases, genetic diseases, and for anti-virus; pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the immune system, pharmaceutical preparations for the treatment of autoimmune diseases, metabolic diseases, blood diseases, diabetes, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, reproductive system diseases and disorders, namely uterine fibroids, endometriosis, benign prostatic hyperplasia and polycystic ovarian syndrome, respiratory system diseases, central and peripheral nervous system diseases, genetic diseases, and for anti-virus; chemico-pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the immune system, pharmaceutical preparations for the treatment of autoimmune diseases, metabolic diseases, blood diseases, diabetes, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, reproductive system diseases and disorders, namely uterine fibroids, endometriosis, benign prostatic hyperplasia and polycystic ovarian syndrome, respiratory system diseases, central and peripheral nervous system diseases, genetic diseases, and for anti-virus; chemical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the immune system, pharmaceutical preparations for the treatment of autoimmune diseases, metabolic diseases, blood diseases, diabetes, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, pharmaceutical preparations for the treatment of genito urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, reproductive system diseases and disorders, namely uterine fibroids, endometriosis, benign prostatic hyperplasia and polycystic ovarian syndrome, respiratory system diseases, central and peripheral nervous system diseases, genetic diseases, and for anti-virus; injections, used for treating tumor, ophthalmology diseases, cardiovascular diseases, pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the immune system, pharmaceutical preparations for the treatment of autoimmune diseases, metabolic diseases, blood diseases, diabetes, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, reproductive system diseases and disorders, namely uterine fibroids, endometriosis, benign prostatic hyperplasia and polycystic ovarian syndrome, respiratory system diseases, central and peripheral nervous system diseases, genetic diseases, and for anti-virus; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the immune system, pharmaceutical preparations for the treatment of autoimmune diseases, metabolic diseases, blood diseases, diabetes, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, pharmaceutical preparations for the treatment of genito urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, reproductive system diseases and disorders, namely uterine fibroids, endometriosis, benign prostatic hyperplasia and polycystic ovarian syndrome, respiratory system diseases, central and peripheral nervous system diseases, genetic diseases, and for anti-virus; vaccines for human use; diagnostic preparations for medical purposes, namely, clinical diagnostic reagents, diagnostic biomarkers reagents for medical purposes, diagnostic preparations for clinical laboratory use and diagnostic preparations for medical laboratory use, medical diagnostic reagents; dietetic preparations consisting of vitamins, minerals and trace elements; antibiotics. (2) Drugs for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the immune system, pharmaceutical preparations for the treatment of autoimmune diseases, metabolic diseases, blood diseases, diabetes, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, reproductive system diseases and disorders, namely uterine fibroids, endometriosis, benign prostatic hyperplasia and polycystic ovarian syndrome, respiratory system diseases, central and peripheral nervous system diseases, genetic diseases, and for anti-virus; biological tissue cultures for medical purposes; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceutical preparations for general health and well being. (1) Providing commercial information and advice for consumers in the field of pharmaceutical preparations; retail and whole sale services of pharmaceutical and veterinary preparations and medical supplies; retail and whole sale services of sanitary preparations; market studies; advertising the goods and services of others; retail and whole sale services of medicines; retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and whole sale services of pharmaceutical preparations; wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies. (2) Technical research in the fields of pharmaceutical and veterinary preparations, in the fields of pharmaceutical studies on cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; conducting technical project studies in the fields of pharmaceutical studies on cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; research and development of new products for others; scientific laboratory services, namely, medical research laboratory services, medical laboratory services for diagnostic and treatment purposes provided by medical laboratories; scientific research, namely, providing medical and scientific research information in the field of pharmaceuticals, medical research, pharmaceutical research services; technical writing; bacteriological research; biological research; clinical trials; chemical research.

86. TYVTYR

Numéro d'application	192924600
Statut	Enregistrée
Date de dépôt	2018-11-07
Date d'enregistrement	2021-10-08
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations namely, anti-inflammatories; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; anti-inflammatory pharmaceutical preparations; anti-infective pharmaceutical preparations; pharmaceutical preparations for autoimmune diseases and immunologic deficiency syndromes; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for the treatment of hepatitis; pharmaceutical preparations for the treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of kidney diseases and disorders

87.

TALTZ Z

Numéro d'application	192440500
Statut	Enregistrée
Date de dépôt	2018-10-10
Date d'enregistrement	2019-11-27
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Pharmaceutical preparations for the treatment of autoimmune diseases and disorders (1) Medical information in the field of autoimmune diseases and disorders and psoriasis

88. LLY

Numéro d'application	191762700
Statut	Enregistrée
Date de dépôt	2018-08-30
Date d'enregistrement	2020-02-03
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

89.

VERZENIO

Numéro d'application	190921800
Statut	Enregistrée
Date de dépôt	2018-07-12
Date d'enregistrement	2019-11-27
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer (1) Medical information services in the field of cancer

90. STYLAPEN

Numéro d'application	190921900
Statut	Enregistrée
Date de dépôt	2018-07-12
Date d'enregistrement	2021-01-20
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques 10 - Appareils et instruments médicaux

Produits et services

(1) Pharmaceutical preparations in delivery devices such as hypodermic injectors and pumps for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, diabetes, inflammatory bowel disease and migraines (2) Hypodermic injectors for use with injection syringes and needles

91. JORLANTA

Numéro d'application	189686100
Statut	Enregistrée
Date de dépôt	2018-05-01
Date d'enregistrement	2020-06-24
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and livestock; veterinary preparations for enhancing reproduction in livestock; immunorestorative biopharmaceuticals and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals namely, Ketosis, Brucellosis, hypomagnesemia, milk fever, fat cow syndrome, E. Coli, salmonella, mad cow disease, Cryptosporidium, Campylobacter, bacillus anthracis; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; veterinary hormone preparations and hormone preparations in the nature of biological implants for animals, namely, progesterone, estrogen and testosterone; veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat; veterinary preparations for companion animals, namely to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders; veterinary preparations for companion animals for nonsurgical sterilization, namely, hormones for the control/prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely vaccines for companion animals including horses; veterinary preparations to control infectious diseases and parasites in fish, namely, vaccines, parasiticides and insecticides.

92. RAYVOW

Numéro d'application	189635200
Statut	Enregistrée
Date de dépôt	2018-04-30
Date d'enregistrement	2020-04-16
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain.

93. LUMJEV

Numéro d'application	189599700
Statut	Enregistrée
Date de dépôt	2018-04-26
Date d'enregistrement	2020-03-24
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

94. OLUMIANCE

Numéro d'application	189456600
Statut	Enregistrée
Date de dépôt	2018-04-18
Date d'enregistrement	2019-11-27
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations, namely pharmaceutical preparations for treating autoimmune diseases and disorders and psoriasis

95. QUESH

Numéro d'application	189426800
Statut	Enregistrée
Date de dépôt	2018-04-17
Date d'enregistrement	2020-01-28
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases. central nervous system diseases and disorders namely, anxiety disorders, depression. bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type I Diabetes Mellitus, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel disease, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

96. XARMODY

Numéro d'application	189426900
Statut	Enregistrée
Date de dépôt	2018-04-17
Date d'enregistrement	2020-01-08
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

97. BIMIERE

Numéro d'application	189426500
Statut	Enregistrée
Date de dépôt	2018-04-17
Date d'enregistrement	2020-01-28
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

98. OLUMIANT

Numéro d'application	189426700
Statut	Enregistrée
Date de dépôt	2018-04-17
Date d'enregistrement	2019-08-29
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases. central nervous system diseases and disorders namely, anxiety disorders, depression. bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type I Diabetes Mellitus, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel disease, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

99. IVESU

Numéro d'application	188953800
Statut	Enregistrée
Date de dépôt	2018-03-22
Date d'enregistrement	2020-01-08
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

100. AFESU

Numéro d'application	188953900
Statut	Enregistrée
Date de dépôt	2018-03-22
Date d'enregistrement	2022-06-30
Propriétaire	Eli Lilly and Company (USA)
Classes de Nice ?	05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, dyslipidemia, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

1 2 3 Prochaine page